|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
 |
October 22, 2019
|
|
|
 |
|
|
ASCA Highlights
Learn how to keep your patients and staff safe with an effective medication management program during ASCA’s upcoming webinar, Pharmacy Medication Management in the ASC, scheduled for Tuesday, October 29, at 1:00 pm ET. This webinar is free for ASCA members and $150 for nonmembers. Register today.
 |
|
 |
|
Echelon Medical Capital offers innovative accounts receivable liquidity solutions for healthcare providers that take insurance or medical liens against pending personal injury cases. Echelon Medical Capital has quickly become one of the largest dedicated medical receivables funding companies in the country. With unrivaled levels of committed capital, Echelon can support medical practices of any size, including doctors, hospitals and surgery centers. |
|
|
Sign up by November 15 to lock in the early bird registration rates for the ASCA 2020 Winter Seminar, January 16–18 in New Orleans, LA. This year’s program features three specialized tracks: ASC Management, Coding & Reimbursement and—back this year by popular demand—Finance & Accounting.
Attendees can move freely between the tracks and join any of the sessions offered throughout the seminar. Check out the schedule and register today!
With your ASCA membership comes a variety of benefits that help you run your ASC more efficiently, provide quality patient care and stay up on industry trends and regulations. See all the ways in which this member puts her ASCA benefits to good use, then renew your membership via the online portal or return the renewal form you receive in the mail later this month.
Not yet an ASCA member? Join today!
|
|
 |
|
Infection is the most common cause of total knee revisions, and the third most common in total hips. In fact, by 2030 the infection risk for hip and knee arthroplasty is expected to increase threefold.
If you’re doing total joints today, or planning to do them in the future, it’s important to have the tools and knowledge needed to prevent, diagnose and treat surgical site infections (SSIs).
What’s your plan to reduce SSIs? Click here for 4 tips to consider as part of your pre-op protocols. |
|
|
Data collection for the third quarter (Q3) of ASCA’s 2019 Clinical & Operational Benchmarking Survey closes next Thursday, October 31. Subscribers should make sure to submit their data by the deadline to get a complete picture of trends for the year.
Not yet subscribed to the 2019 survey? Purchase a subscription now.
Several studies find that patient outcomes at surgery centers are equal to or better than other sites of service. Facts-based and data-based studies that show ASCs provide high-quality and low-cost care make for a powerful tool to educate legislators. Read this ASC Focus Digital Debut to learn more about three of these studies.
The US Drug Enforcement Administration (DEA) is proposing to establish the 2020 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and an assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine and phenylpropanolamine. Read more.
Industry News
Medline and Ambulatory Surgery Center Association Take to Capitol Hill
Medline (10/17/19)
Medline's Ambulatory Surgery Center (ASC) division recently participated in the Ambulatory Surgery Center Association's (ASCA) National Advocacy Day in Washington D.C. to educate members of the U.S. Congress on the most urgent issues facing the ASC community and its patients: Access to Care; Quality, Reporting, [and] Transparency; and Transparency into Medicare Procedure Approval Process. The Medline ASC team and 54 ASCA members from 15 different states visited representatives to discuss pending bills, including H. R. 4350 and H. R. 1570.
SSIs Rare in Orthopedic Surgery in ASC
Docwire News (10/16/19) D'Onofrio, Kaitlyn
The incidence of surgical site infections following orthopedic surgery performed in ambulatory surgical centers (ASCs) is low, according to a recent study published in the Journal of the AAOS; however, certain patients may be at higher risk. "The purpose of this study was to assess the incidence of surgical site infections at a high-volume ASC and to identify patient and surgical risk factors associated with increased risk of infection," the study authors wrote.
Get a Heads Up on Medication Storage in Office-Based Surgery
Joint Commission Ambulatory Buzz blog (10/16/19) DeMarzo, Brigette
We're excited to share that Joint Commission launched a new survey readiness resource, the HEADS UP Report, which provides organizations with a "heads up" or notice about ongoing survey trends as they are observed. Our ambulatory care and office-based surgery programs are included in the first round to receive this report.
|
|
 |
|
Download Now
Do you have the tools and intel to gauge performance across all functions of your revenue cycle? As a leading provider of cost-effective billing and collection services for ASCs, Regent Revenue Cycle Management recently published ASC-specific benchmarks and our own gold standards. Download today and receive the paper and a case study highlighting how one center increased collections by $125,000 per month, due in part to A/R Follow Up. |
|
|
Exact Sciences, Mayo Clinic Launch 150,000-Strong Cologuard Study
Fierce Biotech (10/14/19) Hale, Conor
Exact Sciences and the Mayo Clinic have launched a real-world study that aims to enroll at least 150,000 people to track the impact of the Cologuard colorectal cancer screening test as the company looks to establish it as the standard of care. The seven-year clinical outcomes study aims to chart incidence and mortality rates nationwide among people with an average risk of cancer who have been prescribed and completed the at-home stool test.
Across the U.S., Over 700 Doctors Were Paid More Than a Million Dollars by Drug and Medical-Device Companies Since 2014
Philadelphia Inquirer (10/21/19) Ornstein, Charles; Weber, Tracy; Jones, Ryann Grochowski
Back in 2013, ProPublica detailed what seemed a stunning development in the pharmaceutical industry’s drive to win the prescription pads of the nation's doctors: In just four years, one doctor had earned $1 million giving promotional talks and consulting for drug companies; 21 others had made more than $500,000. Six years later — despite often damning scrutiny from prosecutors and academics — such high earnings have become commonplace.
|
|
|
|
|
|
|